Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert Bourla says the company is betting big on cancer breakthroughs. He also voiced a personal belief that cures for ...

Chris Boshoff has had a busy first year as CSO and President of R&D at Pfizer. First, there were the organizational changes. Boshoff, the company’s previous chief oncology officer, joined Pfizer in ...